Our Focus

Precision Medicine

Precision medicine refers to the tailoring of medical treatment to the individual characteristics of each patient…


Coronavirus and COVID-19

COVID-19 is the disease caused by SARS-CoV-2, a new coronavirus identified in late 2019.  As of Sept 2020, there is no approved vaccine or curative therapy for COVID-19.

Cardiovascular Disease and Atrial Fibrillation

Cardiovascular disease is the No. 1 cause of death in the United States and a major economic burden on the healthcare system…


AB201 - A Potential Treatment for COVID-19

AB201 is a potent, selective inhibitor of tissue factor (TF), which has been identified as playing a central role in the inflammatory response to viral infections and in the process of viral dissemination. Its unique mechanism of action gives AB210 a combination of anti-coagulant, immuno-modulation and anti-viral properties, and therefore the potential to be effective in addressing the pathologies caused by viral infections from multiple aspects.

Gencaro™ — An Unmet Need


Gencaro™ is a pharmacologically unique beta-blocker and mild vasodilator that we are evaluating in a clinical trial for the treatment of atrial fibrillation…